Related Experiment Video
Updated: Jan 11, 2026

Comparative Proteomic Analysis of Whole Kidney, Medulla, and Cortical Tubules in Diabetic Pathogenesis of Kidney Injury in Mice
Published on: May 2, 2025
Alternative pathway-mediated tubular complement activation in human proteinuric kidney diseases: a proof-of-concept
Firas F Alkaff1,2, Rosa G M Lammerts3, Gesa Tiller1
1Division of Nephrology, Department of Internal Medicine, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
Proteinuria can cause kidney damage via tubular complement activation. This study shows the alternative pathway, initiated by properdin and syndecan-1, is key in proteinuric kidney diseases.
Area of Science:
- Nephrology
- Immunology
- Complement System Biology
Background:
- Proteinuria is a significant risk factor for progressive kidney injury.
- Tubular complement activation is a proposed mechanism contributing to kidney damage in proteinuria.
- The role of the alternative complement pathway in human proteinuric kidney diseases remains understudied.
Purpose of the Study:
- To investigate the specific complement pathways involved in apical tubular injury in human proteinuric kidney diseases.
- To determine the association between complement deposition, syndecan-1, and proteinuria levels.
- To explore the potential role of the alternative pathway in initiating tubular complement activation.
Main Methods:
- Analysis of 21 kidney biopsies from patients with proteinuric kidney diseases.
- Immunohistochemical staining for complement components (MASP-2, C1q, properdin, C3d, C5b-9) and syndecan-1.
- Semi-quantitative scoring of complement deposition and measurement of plasma and urinary soluble C5b-9.
Main Results:
- All biopsies exhibited apical proximal tubular C3d deposition, predominantly co-localizing with properdin.
- Tubular properdin deposition correlated significantly with C5b-9 deposition and was associated with syndecan-1.
- Higher proteinuria levels were observed in patients with tubular C5b-9 deposition and detectable urinary soluble C5b-9.
Conclusions:
- Apical tubular complement activation in proteinuric kidney diseases primarily involves the alternative pathway.
- Properdin binding to syndecan-1 is a likely initiator of this alternative pathway activation.
- Targeting the alternative complement pathway may offer a therapeutic strategy for proteinuric kidney diseases.
More Related Videos
09:40Isolation, Characterization, And High Throughput Extracellular Flux Analysis of Mouse Primary Renal Tubular Epithelial Cells
Published on: June 20, 2018
07:06Isolation of Primary Human Proximal Tubule Epithelial Cells and Their Use in Creating a Microphysiological Model of the Renal Proximal Tubule
Published on: May 9, 2025
Related Concept Videos
Drug Elimination by Renal Route: Tubular Secretion
Acute Kidney Injury II: Pathophysiology
Renal Drug Excretion: Tubular Secretion
Renal Corpuscle
Glomerulus: Structure and Function
The glomerulus is a tiny, intricate network of capillaries located at the beginning of the nephron. It's enveloped by the Bowman's capsule and receives its blood supply from an afferent arteriole, which divides into numerous...
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Chronic Kidney Disease I: Introduction